Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06944847 · ClinicalTrials.gov registry record · NA
Vaping and Smoking Project in People With Schizophrenia
A NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06944847 is a NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06944847, a NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.
Conditions Studied
Interventions
- BEHAVIORAL Acute (24-hour) abstinence
- BEHAVIORAL Ad libitum smoking/vaping
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-02-15 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06944847
The ClinicalTrials.gov registry entry for NCT06944847 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) appearing as the primary indexed condition, and to 2 interventions - of which Acute (24-hour) abstinence is the first listed.
NCT06944847 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06944847 about?
NCT06944847 is a clinical study titled "Vaping and Smoking Project in People With Schizophrenia". The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the...
What is the current status of trial NCT06944847?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-02-15. Estimated completion is 2027-04-01.
What conditions does trial NCT06944847 study?
This clinical trial studies the following conditions: Acute Abstinence From Cigarettes vs E-cigarettes (ENDS).
What interventions are being tested in trial NCT06944847?
The interventions under investigation include: Acute (24-hour) abstinence (BEHAVIORAL), Ad libitum smoking/vaping (BEHAVIORAL).
Who is sponsoring clinical trial NCT06944847?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06944847 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.